AllianceBernstein Portfolio holdings
AllianceBernstein (AB), formed in 2000 through the merger of Alliance Capital and Bernstein, is a global asset management firm headquartered in Nashville, Tennessee, managing over $759 billion in assets as of late 2024 for institutional investors, financial advisors, and individuals. Known for its research-driven approach, AB offers a diverse range of investment strategies, including equities, fixed income, alternatives, and multi-asset solutions, with a strong emphasis on active management and ESG (environmental, social, governance) integration. The firm, which relocated its headquarters from New York City to Nashville in 2021, operates globally with significant operations in New York, London, and Asia, leveraging its Bernstein Research arm for deep market insights. With a workforce of over 4,700 and a partnership structure led by CEO Seth Bernstein, AB combines a legacy of rigorous analysis with a modern focus on sustainable investing and client outcomes.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Micron Technology
MU
|
+$1.21B |
| 2 |
Advanced Micro Devices
AMD
|
+$1.15B |
| 3 |
Quanta Services
PWR
|
+$691M |
| 4 |
Trane Technologies
TT
|
+$684M |
| 5 |
RTX Corp
RTX
|
+$655M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$3.74B |
| 2 |
Microsoft
MSFT
|
+$2.35B |
| 3 |
Broadcom
AVGO
|
+$744M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$636M |
| 5 |
TSMC
TSM
|
+$590M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.92% |
| 2 | Miscellaneous | 10.92% |
| 3 | Healthcare | 10.85% |
| 4 | Consumer Discretionary | 10.12% |
| 5 | Financials | 9.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3076
Eve Holding
EVEX
$572M
| $243K | ﹤0.01% |
97,810
+22,330
| +30% | +$64.3K |
2024 Q2
8 quarters
|
|
3077
Sutro Biopharma
STRO
$155M
| $242K | ﹤0.01% |
+7,300
| New | +$228K |
2026 Q2
0 quarters
|
|
3078
908 Devices
MASS
$475M
| $242K | ﹤0.01% |
39,550
+6,400
| +19% | +$49.1K |
2022 Q3
15 quarters
|
|
3079
Pure Cycle
PCYO
$260M
| $242K | ﹤0.01% |
24,020
+2,100
| +10% | +$23K |
2023 Q3
11 quarters
|
|
3080
Autohome
ATHM
$2.34B
| $241K | ﹤0.01% |
+13,903
| New | +$251K |
2026 Q2
0 quarters
|
|
3081
LENZ Therapeutics
LENZ
$99.3M
| $241K | ﹤0.01% |
26,386
+13,000
| +97% | +$105K |
2024 Q3
7 quarters
|
|
3082
JOYY Inc
JOYY
$4.08B
| $241K | ﹤0.01% |
4,131
| – | – |
2025 Q2
4 quarters
|
|
3083
Lifeway Foods
LWAY
$339M
| $241K | ﹤0.01% |
12,450
+3,200
| +35% | +$81.4K |
2025 Q2
4 quarters
|
|
3084
Heron Therapeutics
HRTX
$57.5M
| $240K | ﹤0.01% |
299,910
+101,360
| +51% | +$81.3K |
2014 Q2
48 quarters
|
|
3085
Delcath Systems
DCTH
$500M
| $239K | ﹤0.01% |
25,800
+11,800
| +84% | +$130K |
2025 Q2
4 quarters
|
|
3086
ClearPoint Neuro
CLPT
$279M
| $239K | ﹤0.01% |
26,300
+10,500
| +66% | +$131K |
2025 Q3
3 quarters
|
|
3087
DELISTED
Xoma
XOMA
| $239K | ﹤0.01% |
+7,620
| New | +$309K |
2026 Q2
0 quarters
|
|
3088
Niagen Bioscience
NAGE
$192M
| $239K | ﹤0.01% |
54,150
-268,811
| -83% | -$1.09M |
2024 Q2
8 quarters
|
|
3089
Natural Gas Services Group
NGS
$399M
| $239K | ﹤0.01% |
+6,320
| New | +$257K |
2026 Q2
0 quarters
|
|
3090
Invesco Senior Loan ETF
BKLN
$6.14B
| $238K | ﹤0.01% |
+11,665
| New | +$239K |
2026 Q2
0 quarters
|
|
3091
Designer Brands
DBI
$325M
| $237K | ﹤0.01% |
41,720
+9,400
| +29% | +$66.1K |
2013 Q2
52 quarters
|
|
3092
Vanguard Consumer Discretionary ETF
VCR
$5.83B
| $237K | ﹤0.01% |
661
| – | – |
2023 Q4
10 quarters
|
|
3093
Xperi
XPER
$253M
| $237K | ﹤0.01% |
42,277
+4,982
| +13% | +$36.1K |
2022 Q4
14 quarters
|
|
3094
Alto Ingredients
ALTO
$280M
| $236K | ﹤0.01% |
+48,780
| New | +$249K |
2026 Q2
0 quarters
|
|
3095
Cricut
CRCT
$1.31B
| $235K | ﹤0.01% |
62,800
+10,400
| +20% | +$44.5K |
2023 Q2
12 quarters
|
|
3096
Alector
ALEC
$204M
| $234K | ﹤0.01% |
108,940
+16,000
| +17% | +$34.3K |
2019 Q2
28 quarters
|
|
3097
Alta Equipment Group
ALTG
$203M
| $233K | ﹤0.01% |
43,470
+5,200
| +14% | +$34.9K |
2024 Q2
8 quarters
|
|
3098
Lightbridge
LTBR
$179M
| $232K | ﹤0.01% |
+21,800
| New | +$246K |
2026 Q2
0 quarters
|
|
3099
Takeda Pharmaceutical
TAK
$64.7B
| $232K | ﹤0.01% |
12,522
+1,780
| +17% | +$29.5K |
2026 Q1
1 quarter
|
|
3100
LifeMD
LFMD
$103M
| $231K | ﹤0.01% |
63,960
+19,200
| +43% | +$84.7K |
2024 Q2
8 quarters
|
|
Similar funds
AllianceBernstein's Q2 2026 Portfolio in Review
As of Q2 2026, AllianceBernstein held 3,456 positions worth $302B, down 2.1% from $309B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
AllianceBernstein withdrew a net $10.1B in Q2 2026, closing 139 positions and reducing 1,179 holdings. Its most notable exit was Hologic, an estimated $75.9M position sold in full.
By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 29% a quarter earlier, followed by Miscellaneous and Healthcare.
Against the trend, AllianceBernstein opened a new position in Honeywell Aerospace worth $183M.
- AllianceBernstein's largest Q2 2026 buy was Honeywell Aerospace: 827,059 shares worth $183M.
- AllianceBernstein added most to Micron Technology in Q2 2026, an estimated $1.21B increase.
- AllianceBernstein's biggest Q2 2026 reduction was Amazon, cutting an estimated $3.74B.
- AllianceBernstein fully exited Hologic in Q2 2026, selling an estimated $75.9M.
- AllianceBernstein's ten largest holdings make up 31% of its $302B portfolio in Q2 2026.
- AllianceBernstein opened 228 new positions and closed 139 in Q2 2026.
- AllianceBernstein's portfolio value fell 2.1% quarter-over-quarter to $302B.
Based on AllianceBernstein's 13F filing for Q2 2026, filed 14 Aug 2026.